AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2021

Apr 2, 2021

29831_dirs_2021-04-02_e2bec45c-9b4c-4453-a56d-f262148db021.zip

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-04-02

Reporting Person: SMITH JAMES C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-02	Phantom Stock Units	$	A	1153.5810	Acquired		Common Stock (1153.5810)	Direct

Footnotes

F1: Each unit represents one phantom share of common stock.

F2: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F3: Price is the closing price of Pfizer common stock on April 1, 2021.